MiMedx Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	418.63	348.88	321.48	267.84	242.02
Revenue Growth (YoY)	19.99%	8.52%	20.03%	10.67%	-2.50%
Cost of Revenue	73.01	60.07	54.63	48.32	39.63
Gross Profit	345.62	288.81	266.84	219.53	202.39
Selling, General & Admin	266.19	216.39	216.3	220.85	198.64
Research & Development	15.1	12.34	12.67	12.7	9.93
Amortization of Goodwill & Intangibles	0.44	0.77	0.76	0.7	0.82
Operating Expenses	281.73	229.5	229.73	234.25	209.39
Operating Income	63.89	59.31	37.12	-14.73	-7
Interest Expense	2.93	-3.94	-6.58	-5.05	-4.98
Interest & Investment Income	-	2.93	0.12	0.03	-
Other Non Operating Income (Expenses)	-0.56	-0.57	-0.03	-0	-0.02
EBT Excluding Unusual Items	66.26	57.74	30.63	-19.75	-12
Asset Writedown	-	-0.45	-	-	-0.05
Pretax Income	66.26	57.29	30.63	-19.75	-12.05
Income Tax Expense	17.68	15.3	-36.81	0.21	0.25
Earnings From Continuing Operations	48.58	42	67.44	-19.95	-12.3
Earnings From Discontinued Operations	-	0.42	-9.21	-10.24	2.02
Net Income	48.58	42.42	58.23	-30.2	-10.29
Preferred Dividends & Other Adjustments	-	-	11.64	6.58	6.14
Net Income to Common	48.58	42.42	46.59	-36.78	-16.42
Net Income Growth	14.52%	-27.15%	-	-	-
Shares Outstanding (Basic)	148	147	116	113	110
Shares Outstanding (Diluted)	150	149	146	113	110
Shares Change (YoY)	0.45%	2.11%	29.27%	2.32%	1.94%
EPS (Basic)	0.33	0.29	0.40	-0.33	-0.15
EPS (Diluted)	0.32	0.28	0.36	-0.33	-0.15
EPS Growth	13.14%	-22.18%	-	-	-
Free Cash Flow	72.97	64.51	24.79	-19.41	-5.2
Free Cash Flow Per Share	0.49	0.43	0.17	-0.17	-0.05
Gross Margin	82.56%	82.78%	83.00%	81.96%	83.63%
Operating Margin	15.26%	17.00%	11.54%	-5.50%	-2.89%
Profit Margin	11.60%	12.16%	14.49%	-13.73%	-6.78%
Free Cash Flow Margin	17.43%	18.49%	7.71%	-7.25%	-2.15%
EBITDA	78.77	65.35	40.54	-10.68	-1.82
EBITDA Margin	18.82%	18.73%	12.61%	-3.99%	-0.75%
D&A For EBITDA	14.88	6.04	3.43	4.05	5.18
EBIT	63.89	59.31	37.12	-14.73	-7
EBIT Margin	15.26%	17.00%	11.54%	-5.50%	-2.89%
Effective Tax Rate	26.69%	26.70%	-	-	-
Advertising Expenses	-	0.6	0.6	0.2	0.1

Updated Feb 25, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q